Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,735 recruiting studies in this area right now.
By phase
- Not applicable9,863
- Phase 24,487
- Phase 12,736
- Phase 1/Phase 21,695
- Phase 31,409
- Phase 2/Phase 3282
- Phase 4263
Top conditions
- Breast Cancer1,239
- Prostate Cancer660
- Cancer657
- Colorectal Cancer499
- Lung Cancer431
- Ovarian Cancer341
- Multiple Myeloma330
- Gastric Cancer302
- Pancreatic Cancer295
- Acute Myeloid Leukemia290
- Hepatocellular Carcinoma285
- Solid Tumor256
- Advanced Solid Tumor254
- Cervical Cancer233
- Head and Neck Cancer229
- Endometrial Cancer207
- Advanced Solid Tumors197
- Esophageal Cancer196
Leading sponsors
- M.D. Anderson Cancer Center452
- Fudan University320
- National Cancer Institute (NCI)291
- Sun Yat-sen University290
- Memorial Sloan Kettering Cancer Center289
- Mayo Clinic237
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences151
- City of Hope Medical Center146
- AstraZeneca131
- University Health Network, Toronto125
Where studies are running
- California1,432
- Texas644
- Arizona513
- Florida437
- Alabama418
- New York410
- Massachusetts343
- Maryland331
- New Jersey267
- Pennsylvania237
Recruiting studies20,735 total
- NCT06773481RecruitingPhase 1
BC008-1A injection for recurrent grade 4 glioma
This trial tests a new injection called BC008-1A for people with a grade 4 glioma (a type of brain cancer) that has come back after standard treatment. The goal is to see if the drug can help control the tumor and improve outcomes.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06773507RecruitingPhase 1
Study of BC008-1A for advanced solid tumors
This trial tests a new drug called BC008-1A for people with advanced esophageal cancer or non-small cell lung cancer that has not responded to standard treatments. The goal is to see if the drug is safe and effective.
TianjinAges 18 years+ - NCT06773533Recruiting
Bone health in breast cancer hormone-blockade patients
This study tracks bone health in breast cancer patients receiving hormone-blocking therapy (aromatase inhibitors, GnRH analogs, or tamoxifen). It aims to understand how these treatments affect bone mineral density.
Bologna, BolognaAges 18 years+ - NCT06773598Recruiting
MRI-based machine learning tool for prostate cancer
This trial tests a computer model that learns from MRI scans to predict prostate cancer. If you have had a prostate MRI showing suspicious areas and are scheduled for a biopsy, joining may help improve how cancer is detected.
BolognaAges 18 years+ - NCT06773624Recruiting
New PET Scan to Find Small Bowel Tumors
This study tests a special PET/CT scan (68Ga-DOTATOC PET/CT-enterography) to locate neuroendocrine tumors in the small bowel more clearly. It may help identify the exact tumor site before surgery.
MilanAges 18 years+ - NCT06773806Recruiting
Chlordecone exposure and prostate cancer in Martinique
This trial studies whether exposure to the pesticide chlordecone affects prostate cancer risk in men living in Martinique. It compares men newly diagnosed with prostate cancer to those without cancer.
Fort-de-FranceAges 18–75 - NCT06773832Recruiting
AI to help doctors find polyps during colonoscopy
This trial uses artificial intelligence to help doctors better identify and classify polyps during a routine colonoscopy. It may lead to more accurate detection and fewer missed abnormalities.
BeijingAges 18 years+ - NCT06773897Recruiting
Genetics of Breast Cancer Study
This study looks at the genetics of breast cancer by collecting DNA from a saliva sample and asking you to fill out a health survey online. It's open to anyone in the U.S. who is 18 or older and can complete the study materials in English.
Piscataway, New JerseyAges 18 years+ - NCT06774027Recruiting
Breast cancer antibody-drug conjugate treatment registry
This study tracks how well antibody-drug conjugates (ADCs) work for breast cancer that has spread. You may join if you are about to start your first or second ADC for hormone receptor-positive/HER2-negative or triple-negative breast cancer.
San Francisco, CaliforniaAges 18 years+ - NCT06774209Recruiting
Imaging study for pelvic tumors using PET and MRI
This study uses special PET scans to better see and understand pelvic tumors. It may help doctors plan treatment more accurately. You may be able to join if you have a pelvic tumor and can have surgery or a biopsy.
Beijing, Beijing MunicipalityAges 18–70 - NCT06774326Recruiting
Spectral CT to check for heart damage from lymphoma treatment
This study uses a special type of CT scan called spectral CT to see if chemotherapy drugs called anthracyclines can cause heart damage in people with certain lymphomas. The goal is to catch any heart problems early by imaging the heart before, during, and after treatment.
BolognaAges 18 years+ - NCT06774989Recruiting
Drug level monitoring in metastatic melanoma treatment
This trial checks how much of two drugs, encorafenib and binimetinib, remain in your blood while treating advanced melanoma that cannot be removed by surgery. The goal is to learn if drug levels affect how well the treatment works.
Boulogne-BillancourtAges 18 years+ - NCT06774482Recruiting
Comparing radiation treatments for uterine cancer
This study looks back at patients treated with radiation for uterine cancer at Sant'Orsola Polyclinic in Bologna to compare different treatment options and see which ones work best and cause fewer side effects.
BolognaAges 18 years+ - NCT06774677Recruiting
Studying cell communication in hairy cell leukemia for better care
This study looks at how cells talk to each other in hairy cell leukemia, a rare blood cancer. It aims to find ways to improve patient care. Participants may be asked to give blood or tissue samples for research.
Palermo, PAAges 18 years+ - NCT06774690Recruiting
Arterial treatments for primary liver cancer
This study is watching how treatments that deliver medicine or tiny beads directly into the liver's blood supply work for people with liver cancer. If you have liver cancer and are getting or have gotten one of these treatments, this study wants to learn from your experience.
BolognaAges 18 years+ - NCT06774729Recruiting
Predicting tumor spread using MRI in sarcoma or bone cancer
This trial uses MRI scans to create a model that may predict if a musculoskeletal tumor is spreading. It aims to help doctors decide on the best surgical treatment.
BolognaAges 18 years+ - NCT06774781Recruiting
Using MRI to find prostate tumors
This study uses advanced MRI scans to better identify prostate cancer lesions before biopsy or surgery. It may help men who already have suspicious MRI findings and are scheduled for a prostate biopsy or removal.
BolognaAges 18 years+ - NCT06774963RecruitingPhase 1
Study of LNCB74 for advanced solid tumors
This trial tests a new drug called LNCB74 for people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and effective.
Newport Beach, CaliforniaAges 18 years+ - NCT06775080RecruitingPhase 2
Testing propranolol before and after surgery for stomach or colon cancer
This trial tests if taking a medicine called propranolol around the time of surgery can improve outcomes for people with stomach or colon cancer that can be removed with an operation. Propranolol is a type of drug that blocks certain stress signals in the body and may help with recovery.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT06775470Recruiting
How BRCA gene variants affect ovarian cancer treatment results
This study looks at how different BRCA gene changes affect how well ovarian cancer responds to treatment and the long-term outlook. If you were diagnosed with ovarian cancer and had BRCA testing at Bologna's S.Orsola hospital, your data could help researchers better understand treatment outcomes.
BolognaAges Any age - NCT06775678RecruitingPhase 2
Spatial fragmentation plus low-dose radiation for resistant lung cancer
This study tests whether combining a special type of radiation (spatial fragmentation) with low-dose radiation can help people whose lung cancer stopped responding to immunotherapy and chemotherapy. If you are eligible, you may receive a new treatment approach to try to shrink the tumors.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06775743RecruitingPhase 2
Combination therapy and radiation for EGFR-mutant lung cancer after resistance
This trial tests whether adding radiation therapy to a drug combination can help people with a specific type of lung cancer that has stopped responding to standard first-line pills. It's for patients whose cancer has a certain gene change (EGFR) and has spread to other parts of the body.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06775977Recruiting
Ultrasound contrast for bladder cancer staging
This trial uses a special ultrasound with contrast dye to get a clearer picture of bladder cancer before any treatment. It aims to improve how doctors determine the stage of the cancer, which helps guide the best treatment plan.
Guangzhou, GuangdongAges 18–75 - NCT06776172Recruiting
Lymph node removal during prostate surgery: a comparison study
This trial tests whether removing pelvic lymph nodes during prostate cancer surgery improves outcomes for men with high-risk prostate cancer. If you have high-risk prostate cancer and no signs of spread, you may be able to join.
AarauAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,735 recruiting oncology studies from the U.S. registry right now, out of 32,316 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.